LEADER 04456nam 2200625Ia 450 001 9910140562503321 005 20170815170936.0 010 $a1-282-68660-7 010 $a9786612686603 010 $a0-470-66032-5 010 $a0-470-66034-1 035 $a(CKB)2670000000018924 035 $a(EBL)530046 035 $a(OCoLC)630541218 035 $a(SSID)ssj0000420494 035 $a(PQKBManifestationID)11285542 035 $a(PQKBTitleCode)TC0000420494 035 $a(PQKBWorkID)10392250 035 $a(PQKB)11786452 035 $a(MiAaPQ)EBC530046 035 $a(PPN)249045915 035 $a(EXLCZ)992670000000018924 100 $a20091215d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aIndustrial application of natural fibres$b[electronic resource] $estructure, properties, and technical applications /$fedited by Jo?rg Mu?ssig 210 $aChichester, West Sussex, U.K. ;$aHoboken, NJ $cWiley$d2010 215 $a1 online resource (564 p.) 225 1 $aWiley series in renewable resources 300 $aDescription based upon print version of record. 311 $a0-470-69508-0 320 $aIncludes bibliographical references and index. 327 $aIndustrial Applicationsof Natural Fibres; Contents; Series Preface; Preface; Foreword; List of Contributors; List of Illustrators; PART I BACKGROUND; 1 Historic Usage and Preservation of Cultural Heritage; 2 What Are Natural Fibres?; 2.1 Chemistry of Plant Fibres; 2.2 Natural Fibres - Function in Nature; 2.3 Types of Fibre; 3 Economic Aspects; 3.1 Grades and Standards; 3.2 Technical Applications of Natural Fibres: An Overview; 3.3 Natural Fibres in Technical Applications: Market and Trends; PART II VEGETABLE FIBRES; 4 Flax - Structure, Chemistry, Retting and Processing 327 $a5 Hemp - Cultivation, Extraction and Processing6 Jute - A Versatile Natural Fibre. Cultivation, Extraction and Processing; 7 Abac - Cultivation, Extraction and Processing; 8 Sisal - Cultivation, Processing and Products; 9 Coir - Coconut Cultivation, Extraction and Processing of Coir; 10 Cotton Production and Processing; PART III ANIMAL FIBRES; 11 Mulberry Silk, Spider Dragline and Recombinant Silks; 12 Wool - Structure, Mechanical Properties and Technical Products based on Animal Fibres; PART IV TESTING AND QUALITY MANAGEMENT 327 $a13 Testing Methods for Measuring Physical and Mechanical Fibre Properties (Plant and Animal Fibres)14 SEM Catalogue for Animal and Plant Fibres; 15 Combined (In Situ) Methods; 16 DNA-Analytical Identification of Species and Genetic Modifications in Natural Fibres; 17 Cotton/Worldwide Harmonisation; 18 Flax - ASTM Standardisation and Harmonisation; PART V APPLICATIONS: CURRENT AND POTENTIAL; 19 Composites; 19.1 Historical, Contemporary and Future Applications; 19.2 Design, Material Properties and Databases; 19.3 Natural Fibre Composite Processing: A Technical Overview 327 $a19.4 Natural Fibre-Reinforced Polymers in Automotive Interior Applications19.5 Composites Based on Natural Resources; 19.6 Cellulose Nanocomposites; 20 Insulation Materials Based on Natural Fibres; 21 Natural Fibres in Geotextiles for Soil Protection and Erosion Control; Index 330 $aNatural fibres are becoming increasingly popular for use in industrial applications, providing sustainable solutions to support technical innovation. These versatile, natural based materials have applications in a wide range of industries, from textiles and consumer products to the automotive and construction industries. Industrial Applications of Natural Fibres examines the different steps of processing, from natural generation, fibre separation and fibre processing, to the manufacturing of the final product. Each step is linked to fibre properties and characterization, highlighting 410 0$aWiley series in renewable resources. 606 $aPlant fibers$xIndustrial applications 606 $aAnimal fibers$xIndustrial applications 615 0$aPlant fibers$xIndustrial applications. 615 0$aAnimal fibers$xIndustrial applications. 676 $a677 676 $a677.02832 701 $aMu?ssig$b Jo?rg$0986780 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910140562503321 996 $aIndustrial application of natural fibres$92255224 997 $aUNINA LEADER 03994oam 2200757Ia 450 001 9910960118803321 005 20251017110058.0 010 $a9786613044563 010 $a9780309209915 010 $a0309209919 010 $a9781283044561 010 $a1283044560 010 $a9780309158077 010 $a0309158079 035 $a(CKB)2550000000031967 035 $a(EBL)3378753 035 $a(SSID)ssj0000472566 035 $a(PQKBManifestationID)12212326 035 $a(PQKBTitleCode)TC0000472566 035 $a(PQKBWorkID)10453295 035 $a(PQKB)10164132 035 $a(MiAaPQ)EBC3378753 035 $a(Au-PeEL)EBL3378753 035 $a(CaPaEBR)ebr10459089 035 $a(CaONFJC)MIL304456 035 $a(OCoLC)923282998 035 $a(Perlego)4740295 035 $a(DNLM)1549696 035 $a(BIP)32459735 035 $a(EXLCZ)992550000000031967 100 $a20101215h20102010 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aRare diseases and orphan products $eaccelerating research and development /$fCommittee on Accelerating Rare Diseases Research and Orphan Product Development, Board on Health Sciences Policy ; Marilyn J. Field and Thomas F. Boat, editors ; Institute of Medicine of the National Academies 205 $a1st ed. 210 1$aWashington, D.C. :$cNational Academies Press,$d2010. 210 4$dİ2010 215 $a1 online resource (xxi, 420 pages) $cillustrations 300 $aDescription based upon print version of record. 311 0 $a9780309158060 311 0 $a0309158060 320 $aIncludes bibliographical references (p. 249-282) and index. 327 $a""Front Matter""; ""Acknowledgments""; ""Reviewers""; ""Preface""; ""Contents""; ""Boxes, Figures, and Tables""; ""Summary""; ""1 Introduction""; ""2 Profile of Rare Diseases""; ""3 Regulatory Framework for Drugs for Rare Diseases""; ""4 Discovery Research for Rare Diseases and Orphan Product Development""; ""5 Development of New Therapeutic Drugs and Biologics for Rare Diseases""; ""6 Coverage and Reimbursement: Incentives and Disincentives for Product Development""; ""7 Medical Devices: Research and Development for Rare Diseases"" 327 $a""8 Toward an Integrated Approach to Accelerating Research and Product Development for Rare Diseases""; ""References""; ""Appendix A: Study Activities""; ""Appendix B: Innovation and the Orphan Drug Act, 1983-2009: Regulatory and Clinical Characteristics of Approved Orphan Drugs""; ""Appendix C: Medicare Part D Coverage and Reimbursement of Orphan Drugs""; ""Appendix D: Glossary, Abbreviations, and Public Laws""; ""Appendix E: Rare Diseases Clinical Research Network""; ""Appendix F: Advocacy Group Approaches to Accelerating Research and Product Development: Illustrative Examples""; ""Appendix G: Committee and Staff Biographies""; ""Index"" 330 $aRare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development. 606 $aOrphan drugs 606 $aDrugs$xDesign 606 $aRare diseases$xTreatment 615 0$aOrphan drugs. 615 0$aDrugs$xDesign. 615 0$aRare diseases$xTreatment. 676 $a615.19 701 $aField$b Marilyn J$g(Marilyn Jane)$01804195 701 $aBoat$b Thomas F$01803632 712 02$aInstitute of Medicine (U.S.).$bCommittee on Accelerating Rare Diseases Research and Orphan Product Development. 712 02$aNational Academies Press (U.S.) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910960118803321 996 $aRare diseases and orphan products$94358436 997 $aUNINA